ArticleCancer medicine2018

Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models.

Masahiro Matsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.